XTL Biopharmaceuticals Ltd (XTLB)
2.53
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals 1 Year Total Returns (Daily): 102.3% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 102.3% |
May 02, 2024 | 94.23% |
May 01, 2024 | 120.3% |
April 30, 2024 | 131.2% |
April 29, 2024 | 116.1% |
April 26, 2024 | 101.8% |
April 25, 2024 | 96.71% |
April 24, 2024 | 109.8% |
April 23, 2024 | 112.3% |
April 22, 2024 | 117.2% |
April 19, 2024 | 78.32% |
April 18, 2024 | 93.65% |
April 17, 2024 | 87.12% |
April 16, 2024 | 110.8% |
April 15, 2024 | 117.3% |
April 12, 2024 | 114.9% |
April 11, 2024 | 117.3% |
April 10, 2024 | 117.2% |
April 09, 2024 | 150.7% |
April 08, 2024 | 148.3% |
April 05, 2024 | 169.0% |
April 04, 2024 | 146.8% |
April 03, 2024 | 156.2% |
April 02, 2024 | 115.3% |
April 01, 2024 | 129.8% |
Date | Value |
---|---|
March 28, 2024 | 117.8% |
March 27, 2024 | 123.1% |
March 26, 2024 | 153.7% |
March 25, 2024 | 132.2% |
March 22, 2024 | 122.0% |
March 21, 2024 | 89.06% |
March 20, 2024 | 87.40% |
March 19, 2024 | -15.45% |
March 18, 2024 | -5.78% |
March 15, 2024 | -28.46% |
March 14, 2024 | -29.85% |
March 13, 2024 | -22.77% |
March 12, 2024 | -25.00% |
March 11, 2024 | -25.00% |
March 08, 2024 | -28.13% |
March 07, 2024 | -35.12% |
March 06, 2024 | -28.41% |
March 05, 2024 | -30.44% |
March 04, 2024 | -31.19% |
March 01, 2024 | -31.63% |
February 29, 2024 | -37.53% |
February 28, 2024 | -42.58% |
February 27, 2024 | -30.69% |
February 26, 2024 | -36.08% |
February 23, 2024 | -37.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.66%
Minimum
Sep 30 2022
271.5%
Maximum
Apr 06 2021
8.88%
Average
-27.22%
Median
Jan 21 2022
1 Year Total Returns (Daily) Benchmarks
Compugen Ltd | 235.5% |
Pluri Inc | -27.40% |
BioLine Rx Ltd | -41.88% |
Can Fite Biofarma Ltd | 8.85% |
BiomX Inc | 42.19% |